nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxaliplatin—ABCG2—Vismodegib—skin cancer	0.133	0.163	CbGbCtD
Oxaliplatin—ABCG2—Vemurafenib—skin cancer	0.105	0.129	CbGbCtD
Oxaliplatin—CYP1A2—Imiquimod—skin cancer	0.0788	0.0972	CbGbCtD
Oxaliplatin—CYP1B1—Docetaxel—skin cancer	0.0756	0.0932	CbGbCtD
Oxaliplatin—CYP1A1—Dacarbazine—skin cancer	0.0741	0.0914	CbGbCtD
Oxaliplatin—ABCG2—Dactinomycin—skin cancer	0.0696	0.0858	CbGbCtD
Oxaliplatin—CYP2E1—Dacarbazine—skin cancer	0.0572	0.0706	CbGbCtD
Oxaliplatin—ABCG2—Fluorouracil—skin cancer	0.0471	0.058	CbGbCtD
Oxaliplatin—CYP1A2—Vemurafenib—skin cancer	0.0432	0.0533	CbGbCtD
Oxaliplatin—ABCC2—Docetaxel—skin cancer	0.0398	0.049	CbGbCtD
Oxaliplatin—ABCG2—Docetaxel—skin cancer	0.0359	0.0443	CbGbCtD
Oxaliplatin—CYP1A2—Dacarbazine—skin cancer	0.0331	0.0408	CbGbCtD
Oxaliplatin—CYP1A2—Fluorouracil—skin cancer	0.0194	0.0239	CbGbCtD
Oxaliplatin—SOD1—Dopamine metabolism—TYR—skin cancer	0.0101	0.233	CbGpPWpGaD
Oxaliplatin—NQO1—Dopamine metabolism—TYR—skin cancer	0.00861	0.198	CbGpPWpGaD
Oxaliplatin—ATP7A—endothelium—skin cancer	0.00457	0.0315	CbGeAlD
Oxaliplatin—ATP7A—hair follicle—skin cancer	0.0045	0.0309	CbGeAlD
Oxaliplatin—ATP7A—blood vessel—skin cancer	0.00422	0.029	CbGeAlD
Oxaliplatin—SOD1—hair follicle—skin cancer	0.00394	0.0271	CbGeAlD
Oxaliplatin—SLC31A1—hair follicle—skin cancer	0.00384	0.0264	CbGeAlD
Oxaliplatin—GSTM1—blood vessel—skin cancer	0.00351	0.0242	CbGeAlD
Oxaliplatin—GSTT1—neck—skin cancer	0.00341	0.0235	CbGeAlD
Oxaliplatin—ATP7A—nipple—skin cancer	0.00305	0.021	CbGeAlD
Oxaliplatin—MT1A—connective tissue—skin cancer	0.003	0.0206	CbGeAlD
Oxaliplatin—SOD1—nipple—skin cancer	0.00267	0.0184	CbGeAlD
Oxaliplatin—SLC31A1—nipple—skin cancer	0.0026	0.0179	CbGeAlD
Oxaliplatin—GSTM1—neck—skin cancer	0.00251	0.0173	CbGeAlD
Oxaliplatin—MT2A—connective tissue—skin cancer	0.0025	0.0172	CbGeAlD
Oxaliplatin—MPO—endothelium—skin cancer	0.00245	0.0169	CbGeAlD
Oxaliplatin—GSTP1—hair follicle—skin cancer	0.00234	0.0161	CbGeAlD
Oxaliplatin—MPO—blood vessel—skin cancer	0.00226	0.0156	CbGeAlD
Oxaliplatin—MT2A—skin of body—skin cancer	0.00226	0.0155	CbGeAlD
Oxaliplatin—ATP7A—connective tissue—skin cancer	0.00216	0.0149	CbGeAlD
Oxaliplatin—CA4—nerve—skin cancer	0.00213	0.0147	CbGeAlD
Oxaliplatin—MT1A—female reproductive system—skin cancer	0.00211	0.0145	CbGeAlD
Oxaliplatin—ATP7A—epithelium—skin cancer	0.00205	0.0141	CbGeAlD
Oxaliplatin—ATP7B—female reproductive system—skin cancer	0.00189	0.013	CbGeAlD
Oxaliplatin—CYP1B1—hair follicle—skin cancer	0.00184	0.0127	CbGeAlD
Oxaliplatin—MT2A—lymphoid tissue—skin cancer	0.00183	0.0126	CbGeAlD
Oxaliplatin—CYP1A1—skin epidermis—skin cancer	0.00183	0.0126	CbGeAlD
Oxaliplatin—GSTM1—connective tissue—skin cancer	0.0018	0.0124	CbGeAlD
Oxaliplatin—GSTT1—lymphoid tissue—skin cancer	0.00179	0.0123	CbGeAlD
Oxaliplatin—ATP7A—mammalian vulva—skin cancer	0.00178	0.0122	CbGeAlD
Oxaliplatin—NQO1—nipple—skin cancer	0.00178	0.0122	CbGeAlD
Oxaliplatin—MT2A—female reproductive system—skin cancer	0.00176	0.0121	CbGeAlD
Oxaliplatin—NQO1—neck—skin cancer	0.00176	0.0121	CbGeAlD
Oxaliplatin—GSTT1—female reproductive system—skin cancer	0.00172	0.0119	CbGeAlD
Oxaliplatin—GSTM1—skin of body—skin cancer	0.00163	0.0112	CbGeAlD
Oxaliplatin—GSTP1—nipple—skin cancer	0.00159	0.0109	CbGeAlD
Oxaliplatin—ATP7B—head—skin cancer	0.00158	0.0109	CbGeAlD
Oxaliplatin—GSTP1—neck—skin cancer	0.00157	0.0108	CbGeAlD
Oxaliplatin—SOD1—mammalian vulva—skin cancer	0.00156	0.0107	CbGeAlD
Oxaliplatin—SLC31A1—mammalian vulva—skin cancer	0.00152	0.0104	CbGeAlD
Oxaliplatin—SLC22A3—Synaptic Vesicle Pathway—SYP—skin cancer	0.00151	0.0347	CbGpPWpGaD
Oxaliplatin—MT2A—head—skin cancer	0.00147	0.0101	CbGeAlD
Oxaliplatin—GSTT1—head—skin cancer	0.00144	0.0099	CbGeAlD
Oxaliplatin—SLC22A3—nipple—skin cancer	0.00136	0.00935	CbGeAlD
Oxaliplatin—GSTM1—lymphoid tissue—skin cancer	0.00132	0.00905	CbGeAlD
Oxaliplatin—SLC31A1—female reproductive system—skin cancer	0.0013	0.00895	CbGeAlD
Oxaliplatin—GSTM1—female reproductive system—skin cancer	0.00127	0.00873	CbGeAlD
Oxaliplatin—NQO1—connective tissue—skin cancer	0.00126	0.00868	CbGeAlD
Oxaliplatin—MT1A—lymph node—skin cancer	0.00124	0.00851	CbGeAlD
Oxaliplatin—CA4—nipple—skin cancer	0.00121	0.00833	CbGeAlD
Oxaliplatin—CA4—neck—skin cancer	0.0012	0.00825	CbGeAlD
Oxaliplatin—NQO1—epithelium—skin cancer	0.0012	0.00824	CbGeAlD
Oxaliplatin—MPO—connective tissue—skin cancer	0.00116	0.00798	CbGeAlD
Oxaliplatin—NQO1—skin of body—skin cancer	0.00114	0.00784	CbGeAlD
Oxaliplatin—SOD1—FOXA1 transcription factor network—SHH—skin cancer	0.00113	0.026	CbGpPWpGaD
Oxaliplatin—GSTP1—connective tissue—skin cancer	0.00113	0.00776	CbGeAlD
Oxaliplatin—ATP7B—lymph node—skin cancer	0.00111	0.00762	CbGeAlD
Oxaliplatin—MPO—epithelium—skin cancer	0.0011	0.00758	CbGeAlD
Oxaliplatin—SLC31A1—head—skin cancer	0.00109	0.00748	CbGeAlD
Oxaliplatin—GSTP1—epithelium—skin cancer	0.00107	0.00736	CbGeAlD
Oxaliplatin—GSTM1—head—skin cancer	0.00106	0.0073	CbGeAlD
Oxaliplatin—MPO—skin of body—skin cancer	0.00105	0.00721	CbGeAlD
Oxaliplatin—NQO1—mammalian vulva—skin cancer	0.00104	0.00715	CbGeAlD
Oxaliplatin—GSTP1—skin of body—skin cancer	0.00102	0.007	CbGeAlD
Oxaliplatin—SLC22A3—connective tissue—skin cancer	0.000964	0.00663	CbGeAlD
Oxaliplatin—GSTP1—mammalian vulva—skin cancer	0.000929	0.00639	CbGeAlD
Oxaliplatin—CYP1A2—nipple—skin cancer	0.000895	0.00616	CbGeAlD
Oxaliplatin—ATP7A—lymph node—skin cancer	0.000892	0.00614	CbGeAlD
Oxaliplatin—NQO1—female reproductive system—skin cancer	0.00089	0.00612	CbGeAlD
Oxaliplatin—CYP1B1—connective tissue—skin cancer	0.000886	0.0061	CbGeAlD
Oxaliplatin—CYP1A1—nipple—skin cancer	0.000883	0.00608	CbGeAlD
Oxaliplatin—ABCG2—Fluoropyrimidine Activity—XRCC3—skin cancer	0.000872	0.0201	CbGpPWpGaD
Oxaliplatin—MPO—lymphoid tissue—skin cancer	0.000848	0.00583	CbGeAlD
Oxaliplatin—GSTP1—lymphoid tissue—skin cancer	0.000825	0.00567	CbGeAlD
Oxaliplatin—NQO1—Validated transcriptional targets of TAp63 isoforms—SHH—skin cancer	0.000815	0.0187	CbGpPWpGaD
Oxaliplatin—CYP1B1—skin of body—skin cancer	0.0008	0.0055	CbGeAlD
Oxaliplatin—GSTP1—female reproductive system—skin cancer	0.000795	0.00547	CbGeAlD
Oxaliplatin—SLC22A3—mammalian vulva—skin cancer	0.000794	0.00546	CbGeAlD
Oxaliplatin—SOD1—lymph node—skin cancer	0.000781	0.00537	CbGeAlD
Oxaliplatin—SLC31A1—lymph node—skin cancer	0.000761	0.00523	CbGeAlD
Oxaliplatin—SLC31A1—SLC-mediated transmembrane transport—SLC12A2—skin cancer	0.000751	0.0173	CbGpPWpGaD
Oxaliplatin—NQO1—head—skin cancer	0.000743	0.00511	CbGeAlD
Oxaliplatin—GSTM1—lymph node—skin cancer	0.000743	0.00511	CbGeAlD
Oxaliplatin—MPO—head—skin cancer	0.000684	0.0047	CbGeAlD
Oxaliplatin—SLC22A3—female reproductive system—skin cancer	0.00068	0.00468	CbGeAlD
Oxaliplatin—SOD1—AGE/RAGE pathway—FOXO4—skin cancer	0.000666	0.0153	CbGpPWpGaD
Oxaliplatin—GSTP1—head—skin cancer	0.000664	0.00457	CbGeAlD
Oxaliplatin—CYP1B1—lymphoid tissue—skin cancer	0.000648	0.00446	CbGeAlD
Oxaliplatin—ABCC2—female reproductive system—skin cancer	0.000638	0.00439	CbGeAlD
Oxaliplatin—CYP1B1—female reproductive system—skin cancer	0.000625	0.0043	CbGeAlD
Oxaliplatin—CA4—female reproductive system—skin cancer	0.000606	0.00417	CbGeAlD
Oxaliplatin—CYP1A1—epithelium—skin cancer	0.000595	0.00409	CbGeAlD
Oxaliplatin—SLC22A1—head—skin cancer	0.000594	0.00409	CbGeAlD
Oxaliplatin—SLC22A3—head—skin cancer	0.000568	0.00391	CbGeAlD
Oxaliplatin—CYP1A1—skin of body—skin cancer	0.000566	0.00389	CbGeAlD
Oxaliplatin—ABCG2—HIF-1-alpha transcription factor network—PLIN2—skin cancer	0.000554	0.0127	CbGpPWpGaD
Oxaliplatin—ABCG2—mammalian vulva—skin cancer	0.000543	0.00374	CbGeAlD
Oxaliplatin—MT1A—Copper homeostasis—TP53—skin cancer	0.000528	0.0121	CbGpPWpGaD
Oxaliplatin—CYP1B1—head—skin cancer	0.000522	0.00359	CbGeAlD
Oxaliplatin—NQO1—lymph node—skin cancer	0.000521	0.00358	CbGeAlD
Oxaliplatin—CYP1A1—mammalian vulva—skin cancer	0.000516	0.00355	CbGeAlD
Oxaliplatin—CA4—head—skin cancer	0.000506	0.00348	CbGeAlD
Oxaliplatin—MPO—lymph node—skin cancer	0.000479	0.00329	CbGeAlD
Oxaliplatin—ATP7B—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000468	0.0108	CbGpPWpGaD
Oxaliplatin—GSTP1—lymph node—skin cancer	0.000465	0.0032	CbGeAlD
Oxaliplatin—MT2A—AP-1 transcription factor network—CDKN2A—skin cancer	0.000453	0.0104	CbGpPWpGaD
Oxaliplatin—CYP1A1—female reproductive system—skin cancer	0.000442	0.00304	CbGeAlD
Oxaliplatin—CYP2E1—lymphoid tissue—skin cancer	0.000418	0.00287	CbGeAlD
Oxaliplatin—CYP2E1—female reproductive system—skin cancer	0.000403	0.00277	CbGeAlD
Oxaliplatin—ATP7B—Copper homeostasis—TP53—skin cancer	0.0004	0.0092	CbGpPWpGaD
Oxaliplatin—ATP7A—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000398	0.00916	CbGpPWpGaD
Oxaliplatin—SLC22A3—lymph node—skin cancer	0.000398	0.00274	CbGeAlD
Oxaliplatin—SLC31A1—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000382	0.00878	CbGpPWpGaD
Oxaliplatin—ABCC2—lymph node—skin cancer	0.000373	0.00257	CbGeAlD
Oxaliplatin—CYP1A1—head—skin cancer	0.000369	0.00254	CbGeAlD
Oxaliplatin—CYP1B1—lymph node—skin cancer	0.000366	0.00251	CbGeAlD
Oxaliplatin—CA4—lymph node—skin cancer	0.000355	0.00244	CbGeAlD
Oxaliplatin—ATP7A—Copper homeostasis—TP53—skin cancer	0.00034	0.00782	CbGpPWpGaD
Oxaliplatin—CYP2E1—head—skin cancer	0.000337	0.00232	CbGeAlD
Oxaliplatin—SLC31A1—Copper homeostasis—TP53—skin cancer	0.000326	0.0075	CbGpPWpGaD
Oxaliplatin—NQO1—Aryl Hydrocarbon Receptor—PTGS2—skin cancer	0.000323	0.00742	CbGpPWpGaD
Oxaliplatin—MT2A—Copper homeostasis—TP53—skin cancer	0.00032	0.00736	CbGpPWpGaD
Oxaliplatin—ABCG2—Fluoropyrimidine Activity—ERCC2—skin cancer	0.000307	0.00706	CbGpPWpGaD
Oxaliplatin—NQO1—Validated transcriptional targets of TAp63 isoforms—CDKN2A—skin cancer	0.000304	0.00698	CbGpPWpGaD
Oxaliplatin—SLC22A3—SLC-mediated transmembrane transport—SLC12A2—skin cancer	0.000277	0.00636	CbGpPWpGaD
Oxaliplatin—ABCG2—lymph node—skin cancer	0.000272	0.00187	CbGeAlD
Oxaliplatin—SOD1—Amyotrophic lateral sclerosis (ALS)—TP53—skin cancer	0.000263	0.00605	CbGpPWpGaD
Oxaliplatin—CYP1A1—lymph node—skin cancer	0.000258	0.00178	CbGeAlD
Oxaliplatin—GSTM1—C-MYB transcription factor network—CDKN2A—skin cancer	0.000257	0.00592	CbGpPWpGaD
Oxaliplatin—MT2A—AP-1 transcription factor network—TP53—skin cancer	0.000252	0.0058	CbGpPWpGaD
Oxaliplatin—NQO1—Aryl Hydrocarbon Receptor—NRAS—skin cancer	0.000251	0.00578	CbGpPWpGaD
Oxaliplatin—CYP1A1—PPARA activates gene expression—PLIN2—skin cancer	0.000249	0.00573	CbGpPWpGaD
Oxaliplatin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PLIN2—skin cancer	0.000244	0.00561	CbGpPWpGaD
Oxaliplatin—GSTM1—C-MYB transcription factor network—PTGS2—skin cancer	0.000241	0.00553	CbGpPWpGaD
Oxaliplatin—MT2A—AP-1 transcription factor network—IL6—skin cancer	0.000231	0.00531	CbGpPWpGaD
Oxaliplatin—SOD1—Selenium Micronutrient Network—PTGS2—skin cancer	0.000226	0.0052	CbGpPWpGaD
Oxaliplatin—MPO—C-MYB transcription factor network—CDKN2A—skin cancer	0.000219	0.00503	CbGpPWpGaD
Oxaliplatin—ATP7A—Cellular responses to stress—CDK4—skin cancer	0.000218	0.00501	CbGpPWpGaD
Oxaliplatin—NQO1—Aryl Hydrocarbon Receptor—KRAS—skin cancer	0.000216	0.00497	CbGpPWpGaD
Oxaliplatin—MPO—IL23-mediated signaling events—IL6—skin cancer	0.000215	0.00494	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—TLR7—skin cancer	0.000207	0.00477	CbGpPWpGaD
Oxaliplatin—SOD1—Copper homeostasis—TP53—skin cancer	0.000205	0.00471	CbGpPWpGaD
Oxaliplatin—MPO—C-MYB transcription factor network—PTGS2—skin cancer	0.000205	0.00471	CbGpPWpGaD
Oxaliplatin—MPO—Selenium Micronutrient Network—PTGS2—skin cancer	0.000197	0.00453	CbGpPWpGaD
Oxaliplatin—SOD1—Vitamin B12 Metabolism—IL6—skin cancer	0.00019	0.00438	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—PLIN2—skin cancer	0.000189	0.00434	CbGpPWpGaD
Oxaliplatin—GSTM1—C-MYB transcription factor network—NRAS—skin cancer	0.000187	0.00431	CbGpPWpGaD
Oxaliplatin—NQO1—Aryl Hydrocarbon Receptor—HRAS—skin cancer	0.000184	0.00423	CbGpPWpGaD
Oxaliplatin—SLC22A2—SLC-mediated transmembrane transport—SLC12A2—skin cancer	0.000174	0.00399	CbGpPWpGaD
Oxaliplatin—SOD1—Folate Metabolism—TP53—skin cancer	0.000169	0.00389	CbGpPWpGaD
Oxaliplatin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PLIN2—skin cancer	0.000168	0.00386	CbGpPWpGaD
Oxaliplatin—ATP7A—Cellular responses to stress—CDKN2A—skin cancer	0.000167	0.00383	CbGpPWpGaD
Oxaliplatin—MPO—Vitamin B12 Metabolism—IL6—skin cancer	0.000166	0.00382	CbGpPWpGaD
Oxaliplatin—ABCG2—HIF-1-alpha transcription factor network—TERT—skin cancer	0.000165	0.0038	CbGpPWpGaD
Oxaliplatin—SLC22A1—SLC-mediated transmembrane transport—SLC12A2—skin cancer	0.000162	0.00372	CbGpPWpGaD
Oxaliplatin—GSTM1—C-MYB transcription factor network—KRAS—skin cancer	0.000161	0.00371	CbGpPWpGaD
Oxaliplatin—MPO—C-MYB transcription factor network—NRAS—skin cancer	0.000159	0.00366	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor—PTGS2—skin cancer	0.000155	0.00357	CbGpPWpGaD
Oxaliplatin—SOD1—Folate Metabolism—IL6—skin cancer	0.000155	0.00356	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—CSPG4—skin cancer	0.000152	0.0035	CbGpPWpGaD
Oxaliplatin—MPO—Folate Metabolism—TP53—skin cancer	0.000148	0.0034	CbGpPWpGaD
Oxaliplatin—CYP1B1—Arachidonic acid metabolism—PTGS2—skin cancer	0.000145	0.00334	CbGpPWpGaD
Oxaliplatin—SLC22A3—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000141	0.00323	CbGpPWpGaD
Oxaliplatin—MPO—C-MYB transcription factor network—KRAS—skin cancer	0.000137	0.00315	CbGpPWpGaD
Oxaliplatin—GSTM1—C-MYB transcription factor network—HRAS—skin cancer	0.000137	0.00315	CbGpPWpGaD
Oxaliplatin—MPO—Folate Metabolism—IL6—skin cancer	0.000135	0.00311	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—CDK4—skin cancer	0.000131	0.00302	CbGpPWpGaD
Oxaliplatin—SOD1—Selenium Micronutrient Network—IL6—skin cancer	0.000123	0.00283	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—PLIN2—skin cancer	0.000122	0.0028	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor—NRAS—skin cancer	0.000121	0.00277	CbGpPWpGaD
Oxaliplatin—MPO—C-MYB transcription factor network—HRAS—skin cancer	0.000116	0.00268	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—CDK4—skin cancer	0.000115	0.00263	CbGpPWpGaD
Oxaliplatin—ABCG2—Fluoropyrimidine Activity—TP53—skin cancer	0.00011	0.00252	CbGpPWpGaD
Oxaliplatin—MT2A—Cytokine Signaling in Immune system—NRAS—skin cancer	0.000109	0.0025	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	0.000109	0.0025	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—PLIN2—skin cancer	0.000108	0.00248	CbGpPWpGaD
Oxaliplatin—MPO—Selenium Micronutrient Network—IL6—skin cancer	0.000107	0.00247	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—FOXO4—skin cancer	0.000107	0.00246	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor—KRAS—skin cancer	0.000104	0.00239	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—ENO2—skin cancer	0.000103	0.00238	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—PLIN2—skin cancer	0.000103	0.00238	CbGpPWpGaD
Oxaliplatin—ABCC2—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000102	0.00236	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—PLIN2—skin cancer	0.000101	0.00232	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—CDKN2A—skin cancer	0.0001	0.00231	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—CSPG4—skin cancer	9.8e-05	0.00225	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—skin cancer	9.55e-05	0.0022	CbGpPWpGaD
Oxaliplatin—MT2A—Cytokine Signaling in Immune system—KRAS—skin cancer	9.36e-05	0.00215	CbGpPWpGaD
Oxaliplatin—ATP7A—Cellular responses to stress—TP53—skin cancer	9.28e-05	0.00213	CbGpPWpGaD
Oxaliplatin—CYP1A1—Arachidonic acid metabolism—PTGS2—skin cancer	8.94e-05	0.00205	CbGpPWpGaD
Oxaliplatin—ABCG2—Transmembrane transport of small molecules—SLC12A2—skin cancer	8.91e-05	0.00205	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor—HRAS—skin cancer	8.83e-05	0.00203	CbGpPWpGaD
Oxaliplatin—SLC22A2—Transmembrane transport of small molecules—SLC12A2—skin cancer	8.82e-05	0.00203	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—CDKN2A—skin cancer	8.76e-05	0.00201	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—CSPG4—skin cancer	8.69e-05	0.002	CbGpPWpGaD
Oxaliplatin—ATP7A—Cellular responses to stress—IL6—skin cancer	8.49e-05	0.00195	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—CSPG4—skin cancer	8.33e-05	0.00192	CbGpPWpGaD
Oxaliplatin—SLC22A1—Transmembrane transport of small molecules—SLC12A2—skin cancer	8.22e-05	0.00189	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—CSPG4—skin cancer	8.12e-05	0.00187	CbGpPWpGaD
Oxaliplatin—MT2A—Cytokine Signaling in Immune system—HRAS—skin cancer	7.96e-05	0.00183	CbGpPWpGaD
Oxaliplatin—MT2A—Cytokine Signaling in Immune system—IL6—skin cancer	7.62e-05	0.00175	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—skin cancer	7.43e-05	0.00171	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—PLIN2—skin cancer	6.95e-05	0.0016	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	6.69e-05	0.00154	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—ENO2—skin cancer	6.66e-05	0.00153	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—skin cancer	6.4e-05	0.00147	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—skin cancer	6.09e-05	0.0014	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—ERCC2—skin cancer	6e-05	0.00138	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—ENO2—skin cancer	5.91e-05	0.00136	CbGpPWpGaD
Oxaliplatin—CYP1A2—Arachidonic acid metabolism—PTGS2—skin cancer	5.7e-05	0.00131	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—ENO2—skin cancer	5.66e-05	0.0013	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—CSPG4—skin cancer	5.6e-05	0.00129	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—TP53—skin cancer	5.59e-05	0.00128	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—ENO2—skin cancer	5.52e-05	0.00127	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—skin cancer	5.44e-05	0.00125	CbGpPWpGaD
Oxaliplatin—SLC22A2—Transmission across Chemical Synapses—BRAF—skin cancer	5.34e-05	0.00123	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—IL6—skin cancer	5.11e-05	0.00118	CbGpPWpGaD
Oxaliplatin—SLC22A1—Transmission across Chemical Synapses—BRAF—skin cancer	4.97e-05	0.00114	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—TP53—skin cancer	4.87e-05	0.00112	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—PLIN2—skin cancer	4.84e-05	0.00111	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—skin cancer	4.74e-05	0.00109	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—IL6—skin cancer	4.46e-05	0.00103	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—PLIN2—skin cancer	4.4e-05	0.00101	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—PLIN2—skin cancer	4.36e-05	0.001	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—NRAS—skin cancer	4.34e-05	0.000998	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	4.27e-05	0.000981	CbGpPWpGaD
Oxaliplatin—SLC22A2—Neuronal System—BRAF—skin cancer	4.09e-05	0.00094	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—skin cancer	4.08e-05	0.000938	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—PLIN2—skin cancer	4.06e-05	0.000934	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—CSPG4—skin cancer	3.9e-05	0.000897	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—ERCC2—skin cancer	3.87e-05	0.00089	CbGpPWpGaD
Oxaliplatin—SLC22A1—Neuronal System—BRAF—skin cancer	3.81e-05	0.000876	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—ENO2—skin cancer	3.81e-05	0.000875	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—KRAS—skin cancer	3.73e-05	0.000859	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—PTGS2—skin cancer	3.6e-05	0.000828	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—NRAS—skin cancer	3.55e-05	0.000817	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—CSPG4—skin cancer	3.55e-05	0.000816	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—CSPG4—skin cancer	3.51e-05	0.000808	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—skin cancer	3.47e-05	0.000797	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—ERCC2—skin cancer	3.43e-05	0.000789	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—TP53—skin cancer	3.32e-05	0.000763	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—ERCC2—skin cancer	3.29e-05	0.000756	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—CSPG4—skin cancer	3.27e-05	0.000753	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—ERCC2—skin cancer	3.21e-05	0.000737	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—HRAS—skin cancer	3.17e-05	0.00073	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—PLIN2—skin cancer	3.16e-05	0.000727	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—KRAS—skin cancer	3.06e-05	0.000703	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—PLIN2—skin cancer	2.98e-05	0.000685	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—ENO2—skin cancer	2.65e-05	0.00061	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—HRAS—skin cancer	2.6e-05	0.000598	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—CSPG4—skin cancer	2.55e-05	0.000586	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—IL6—skin cancer	2.49e-05	0.000572	CbGpPWpGaD
Oxaliplatin—SLC22A2—Transmission across Chemical Synapses—HRAS—skin cancer	2.45e-05	0.000564	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—ENO2—skin cancer	2.41e-05	0.000555	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—CSPG4—skin cancer	2.4e-05	0.000552	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—ENO2—skin cancer	2.39e-05	0.000549	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—PTGS2—skin cancer	2.32e-05	0.000533	CbGpPWpGaD
Oxaliplatin—SLC22A1—Transmission across Chemical Synapses—HRAS—skin cancer	2.29e-05	0.000526	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—ENO2—skin cancer	2.23e-05	0.000512	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—ERCC2—skin cancer	2.21e-05	0.000508	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	2.07e-05	0.000477	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—PTGS2—skin cancer	2.06e-05	0.000473	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—PTGS2—skin cancer	1.97e-05	0.000454	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—PTGS2—skin cancer	1.92e-05	0.000442	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—PLIN2—skin cancer	1.9e-05	0.000437	CbGpPWpGaD
Oxaliplatin—SLC22A2—Neuronal System—HRAS—skin cancer	1.88e-05	0.000432	CbGpPWpGaD
Oxaliplatin—SLC22A1—Neuronal System—HRAS—skin cancer	1.75e-05	0.000403	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—ENO2—skin cancer	1.73e-05	0.000398	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—ENO2—skin cancer	1.63e-05	0.000375	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—ERCC2—skin cancer	1.54e-05	0.000354	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—CSPG4—skin cancer	1.53e-05	0.000352	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—ERCC2—skin cancer	1.4e-05	0.000322	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—ERCC2—skin cancer	1.39e-05	0.000319	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—PTGS2—skin cancer	1.33e-05	0.000305	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—ERCC2—skin cancer	1.29e-05	0.000297	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.28e-05	0.000294	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—ENO2—skin cancer	1.04e-05	0.000239	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—ERCC2—skin cancer	1.01e-05	0.000231	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—ERCC2—skin cancer	9.49e-06	0.000218	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—PTGS2—skin cancer	9.24e-06	0.000212	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—PTGS2—skin cancer	8.4e-06	0.000193	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—PTGS2—skin cancer	8.32e-06	0.000191	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	8.14e-06	0.000187	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—PTGS2—skin cancer	7.75e-06	0.000178	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—ERCC2—skin cancer	6.05e-06	0.000139	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—PTGS2—skin cancer	6.03e-06	0.000139	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—PTGS2—skin cancer	5.69e-06	0.000131	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—PTGS2—skin cancer	3.63e-06	8.34e-05	CbGpPWpGaD
